000 | 01090 a2200301 4500 | ||
---|---|---|---|
005 | 20250515011419.0 | ||
264 | 0 | _c20060320 | |
008 | 200603s 0 0 eng d | ||
022 | _a1170-229X | ||
024 | 7 |
_a10.2165/00002512-200522120-00003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStaskin, David R | |
245 | 0 | 0 |
_aOveractive bladder in the elderly: a guide to pharmacological management. _h[electronic resource] |
260 |
_bDrugs & aging _c2005 |
||
300 |
_a1013-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBehavior Therapy |
650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscarinic Antagonists _xadverse effects |
650 | 0 | 4 | _aQuantitative Structure-Activity Relationship |
650 | 0 | 4 |
_aUrinary Incontinence _xdiagnosis |
773 | 0 |
_tDrugs & aging _gvol. 22 _gno. 12 _gp. 1013-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002512-200522120-00003 _zAvailable from publisher's website |
999 |
_c15983624 _d15983624 |